Skip to main content
. 2019 Jul 5;39(7):BSR20181824. doi: 10.1042/BSR20181824

Table 5. Stratified analyses between ICOS rs10932029 T>C polymorphism and HCC risk.

Variable ICOS rs10932029 T>C (case/control)1 Adjusted OR2 (95% CI); P
TT TC CC TT TC CC TC/CC CC vs. (TC/TT)
Sex
  Male 379/683 129/143 9/7 1.00 1.47 (1.01–2.12); P: 0.043 1.56 (0.406.18); P: 0.525 1.49 (1.04–2.13); P: 0.031 1.45 (0.375.73); P: 0.595
  Female 41/73 17/14 0/1 1.00 2.39 (0.946.05); P: 0.067 - 2.14 (0.865.29); P: 0.101 -
Age (years)
  <53 197/319 61/72 2/2 1.00 1.41 (0.852.35); P: 0.182 3.36 (0.3433.23); P: 0.301 1.48 (0.892.44); P: 0.128 3.15 (0.3231.09);P: 0.325
  ≥53 223/437 85/85 7/6 1.00 1.70 (1.09–2.64); P: 0.020 0.76 (0.183.18); P: 0.709 1.62 (1.05–2.49); P: 0.029 0.69 (0.172.85); P: 0.603
Smoking status
  Never 271/487 93/102 4/5 1.00 1.50 (1.002.24); P: 0.050 0.97 (0.175.49); P: 0.973 1.49 (1.00–2.22); P: 0.049 0.90 (0.165.08); P: 0.907
  Ever 149/269 53/55 5/3 1.00 1.77 (0.953.31); P: 0.072 1.33 (0.199.37); P: 0.774 1.75 (0.953.20); P: 0.071 1.18 (0.178.21); P: 0.866
Alcohol consumption
  Never 299/635 103/132 6/6 1.00 1.56 (1.07–2.26); P: 0.020 1.41 (0.345.89); P: 0.640 1.57 (1.09–2.26); P: 0.016 1.30 (0.315.41); P: 0.721
  Ever 121/121 43/25 3/2 1.00 1.61 (0.763.43); P: 0.218 0.33 (0.018.03); P: 0.497 1.50 (0.713.16); P: 0.285 0.30 (0.017.01); P: 0.451
Chronic HBV infection
  Yes 296/65 100/19 8/1 1.00 1.08 (0.601.95); P: 0.794 1.66 (0.1914.92); P: 0.650 1.14 (0.642.03); P: 0.657 1.67 (0.1914.96);P: 0.645
  No 124/691 46/138 1/7 1.00 1.85 (1.25–2.73); P: 0.002 0.80 (0.106.60); P: 0.832 1.81 (1.23–2.66); P: 0.003 0.70 (0.085.79);P: 0.740
1

The genotyping was successful in 575 (98.46%) HCC cases and 921 (99.78%) controls for ICOS rs10932029 T>C.

2

Adjusted for age, sex, chronic HBV infection, smoking and alcohol consumption (besides stratified factors accordingly) in a logistic regression model.